Serious About Expanding Access to Methadone
The Senate Committee on Health, Education, Labor, and Pensions is scheduled to consider the Modernizing Opioid Treatment Access Act (MOTAA).
Humility is the Best Medicine
A researcher presents his prescription for better health care: A dose of humility for doctors, nurses and clinicians.
You Might Have Christmas Tree Syndrome
Prolonged exposure to Christmas trees can lead to respiratory and skin health issues, particularly for individuals with asthma or allergies.
Am I Shopping Compulsively?
Compulsive buying during the holiday season can have significant impacts on individuals' mental health and financial well-being.
Have We Cured Sickle Cell Disease?
The development and application of CRISPR-Cas9 bring hope for a cure, addressing the condition at a genetic level.
Learn the New Atrial Fibrillation Guidelines
The new classification recognizes atrial fibrillation as a disease continuum and emphasizes a holistic approach to management.
What is White Lung Pneumonia?
White lung pneumonia, also known as pediatric white lung syndrome, is not exactly a novel pneumonia of unknown origin.
Misrepresenting Physicians in Court
Dr. Ruan explains how the misapplication of the Controlled Substance Act enabled judicial misconduct and led to his conviction.
Focusing on the Jury Instruction on Drug Conspiracy at My Trial
Dr. Ruan explains how biased jury instructions can lead to biased outcomes in criminal cases involving physicians' prescribing behavior.
Nikki Haley’s Influence on Abortion
Nikki Haley is having a political moment. How will her beliefs shape Conservative perspectives on abortion?
Suicide Rates Reach New High
Suicide rates in the United States have seen an alarming rise in recent years, highlighting the urgent need for a ...
Protect Your Medical Credentials
Although Dr. Sasaki didn’t know what was actually going on, he became suspicious after another doctor told him that something ...
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more